Stay updated with breaking news from Sofinnova Partner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MILAN, ITALY / ACCESSWIRE / August 10, 2022 / Nephris, a biotech company developing first-in-class therapies for chronic kidney diseases, extends its congratulations to the researchers from the Romeo and
DGAP-News: Sofinnova Partners / Key word(s): Personnel Sofinnova Partners: AAVantgarde Announces the Appointment of Naveed Shams, M.D., Ph.D. as Chief Development and Medical Officer 30.06.2022 / 08:00 The issuer is solely responsible for the content of this announcement. AAVantgarde Announces t...
The Series A funding will enable completion of the development of the company's unique co-manipulative surgical robotic product and prepare it for a successful commercial launch.PARIS, FRANCE and SAN FRANCISCO
Moon Surgical raised $31.3 million in Series A funding to expand its team and accelerate its Maestro robotic surgery system's development.
Press release content from Accesswire. The AP news staff was not involved in its creation.